Retour sur lavenir.net
   ELIA GROUP 140.000 € (+1,67 %)     D'IETEREN GROUP 180.400 € (+0,56 %)     NYXOAH 1.700 € (+11,26 %)     AB INBEV 72.440 € (+1,86 %)     QRF(SUB)C15 0.035 € (+18,24 %)     ARGENX SE 830.800 € (+0,68 %)     AZELIS GROUP 9.885 € (+2,17 %)     COLRUYT 36.300 € (-0,82 %)     WDP 22.300 € (-0,54 %)     TITAN S.A. 52.000 € (+0,68 %)     SYENSQO 66.300 € (+1,22 %)     JENSEN-GROUP 84.800 € (+0,24 %)     AEDIFICA 69.700 € (+0,07 %)     ECONOCOM GROUP 1.485 € (-1,00 %)     EXMAR 11.000 € (-0,90 %)     NEXTENSA 46.320 € (+0,17 %)     INCLUSIO SA/NV 16.700 € (0,00 %)     VASTNED 29.500 € (-0,17 %)     ASCENCIO 51.900 € (-0,38 %)     CAMPINE 218.000 € (+0,46 %)     PROXIMUS 5.900 € (+0,43 %)     VIOHALCO 19.100 € (+1,06 %)     DEME GROUP 177.400 € (+2,19 %)     TUBIZE-FIN 224.400 € (-1,41 %)     WERELDHAVE BELGIUM 52.800 € (+0,38 %)     GIMV 45.950 € (+0,33 %)     CARE PROPERTY INV. 12.600 € (-1,25 %)     BREDERODE 104.600 € (+0,38 %)     SHURGARD 26.400 € (-0,38 %)     SOFINA 230.600 € (+0,61 %)     LOTUS BAKERIES 11 780.000 € (+1,38 %)     MELEXIS 78.550 € (+1,03 %)     UMICORE 21.360 € (+2,40 %)     TINC 11.260 € (-0,71 %)     CENERGY 23.000 € (+3,88 %)     EVS 27.500 € (+0,36 %)     HYLORIS 4.520 € (+0,89 %)     HOME INVEST BE. 19.200 € (-0,31 %)     BEKAERT 40.650 € (+2,52 %)     FLUXYS BELGIUM D 19.450 € (-1,52 %)     VAN DE VELDE 30.000 € (-0,33 %)     CMB.TECH 13.220 € (+2,48 %)     ONWARD MEDICAL 2.620 € (+0,77 %)     KINEPOLIS GROUP 37.000 € (+1,37 %)     CIE BOIS SAUVAGE 307.000 € (-0,65 %)     BARCO 8.520 € (+1,97 %)     WHAT'S COOKING GP 145.500 € (+3,56 %)     IBA 17.700 € (-0,11 %)     FAGRON 24.600 € (+0,82 %)     MONTEA 67.500 € (-0,59 %)     KBC 120.650 € (-0,86 %)     AGFA-GEVAERT 0.420 € (-0,24 %)     VGP 87.400 € (+0,34 %)     AGEAS 70.700 € (+0,43 %)     BPOST 1.670 € (+5,16 %)     SOLVAY 26.360 € (-0,60 %)     BANQUP GROUP 2.100 € (+0,96 %)     DECEUNINCK 2.275 € (+1,34 %)     TESSENDERLO 20.350 € (+0,25 %)     UCB 259.500 € (-1,93 %)  
   SANOFI 75.810 € (+0,74 %)     GETLINK SE 18.730 € (+1,19 %)     AKZO NOBEL 60.800 € (+1,00 %)     ASR NEDERLAND 66.560 € (-0,03 %)     CAPGEMINI 91.900 € (+0,37 %)     SHELL PLC 33.885 € (-0,24 %)     GENFIT 12.940 € (+22,31 %)     ASM INTERNATIONAL 975.600 € (+4,10 %)     TECHNIP ENERGIES 34.520 € (+3,42 %)     AIR LIQUIDE 180.300 € (+0,16 %)     AHOLD DEL 35.920 € (-0,66 %)     AB SCIENCE 0.773 € (+0,78 %)     ING GROEP N.V. 28.290 € (+0,21 %)     ALLFUNDS GROUP 8.575 € (+0,53 %)     MICHELIN 34.840 € (+0,35 %)     CROSSJECT 1.800 € (+0,67 %)     SBM OFFSHORE 30.680 € (+2,40 %)     DSM FIRMENICH AG 85.000 € (+2,29 %)     ACCOR 50.900 € (+0,35 %)     VALEO 13.275 € (+2,55 %)     VOLTALIA 7.200 € (+1,27 %)     AIR FRANCE -KLM 13.395 € (-0,37 %)     EUROPACORP 0.266 € (+9,92 %)     PHILIPS KON 24.690 € (+1,94 %)     ENGIE 27.730 € (+2,06 %)     LEGRAND 143.350 € (+1,59 %)     DNXCORP 17.750 € (-0,56 %)     UMG 18.995 € (-0,73 %)     ICADE 19.230 € (-0,83 %)     JCDECAUX 20.100 € (+1,11 %)     IPSEN 170.700 € (-0,23 %)     EUROCOMMERCIAL 27.450 € (0,00 %)     GECINA 72.800 € (-0,21 %)     UNILEVER 54.080 € (-0,39 %)     ADYEN 862.300 € (+0,85 %)     TKH GROUP 43.820 € (+2,19 %)     ABC ARBITRAGE 5.260 € (+0,57 %)     L'OREAL 382.450 € (-1,42 %)     STELLANTIS NV 4.930 € (-3,47 %)     AMG 33.080 € (+2,61 %)     SPIE 52.750 € (+5,50 %)     HERMES INTL 1 641.000 € (-0,36 %)     FUGRO 9.475 € (+0,74 %)     EXAIL TECHNOLOGIES 122.500 € (+0,99 %)     ARCADIS 33.780 € (+2,80 %)     S.E.B. 48.780 € (+0,58 %)     DASSAULT SYSTEMES 18.495 € (-0,94 %)     ORANGE 15.860 € (-0,06 %)     RENAULT 26.370 € (+1,66 %)     WOLTERS KLUWER 57.620 € (+0,07 %)     AIRBUS 206.150 € (+1,10 %)     FRANCAISE ENERGIE 42.100 € (+5,25 %)     VALNEVA 2.337 € (+4,10 %)     APERAM 45.500 € (+3,60 %)     THALES 238.200 € (-0,92 %)     ARCELORMITTAL SA 58.600 € (+5,89 %)     AEGON 7.672 € (+0,87 %)     NN GROUP 75.940 € (-0,24 %)     DRONE VOLT 0.389 € (+2,42 %)     BOLLORE 4.144 € (+0,83 %)  
News Réglementées
28/03/2023 14:00

Q'Apel Medical Inc. Granted CE Mark Under MDR for Their Walrus Balloon Guide Catheter

FREMONT, CA / ACCESSWIRE / March 28, 2023 / Q'Apel Medical Inc. was granted the CE Mark under MDR for Walrus, their U.S. market-leading Balloon Guide Catheter (BGC) utilized in treating patients suffering an acute ischemic stroke. The Walrus BGC has been utilized by Neuro Interventional physicians since 2019 and has successfully treated over 20,000 patients in the United States.

The Walrus BGC is a unique development in the field of Mechanical Thrombectomy procedures. It provides physicians with not only the known benefits of BGC use clinically, but unique to Walrus, superior ease of use in preparation in these urgent procedures. Importantly, Walrus enables the physicians to navigate the catheter into a more distal location easily and safely compared to other systems, which is associated with improved patient outcomes from stroke.

"The anticipation of Walrus in our international markets has been enormous, and we look forward to the same performance and loyalty around Walrus we have been fortunate to experience in the United States," said King Nelson, Q'Apel Medical's CEO.

"We are thrilled to be entering the EU and other international markets with Walrus and providing more physicians in more countries the unparalleled performance of our flagship catheter. This CE Mark certification represents a significant growth milestone for Q'Apel Medical providing access to new markets," commented Jodie Fam, Chief Marketing Officer & GM International.

About Q'Apel Medical

Q'Apel Medical designs highly innovative technologies for neurovascular interventions and unmet clinical needs. Q'Apel's portfolio comprises three products, the Walrus Balloon Catheter System, the Wahoo Hybrid Access System and Armadillo Radial Access System. Before Walrus came along, balloon-based variable stiffness catheters brought all manner of technological constraints. Not anymore. By blending flow control, trackability, support, and access into one revolutionary solution, Walrus offers truly unmatched functionality. The Wahoo Hybrid Access System and Armadillo Radial Access System are dual-mode catheters and part of the SelectFlex™ Family of Neurovascular Catheters. These devices feature two distinct operational modes, allowing physicians to easily switch modes at any point during a clinical case and reducing the need for multiple catheters in challenging procedures.

Media Contact: Jodie Fam
415 244 9885

+44 7500702108

jfam@qapelmedical.com
info@qapelmedical.com
www.qapelmedical.com

Contact Information

Jodie Fam
Chief Marketing Officer & GM International
jfam@qapelmedical.com
4152449885

SOURCE: Q'Apel Medical Inc.

.

View source version on accesswire.com:
https://www.accesswire.com/745686/QApel-Medical-Inc-Granted-CE-Mark-Under-MDR-for-Their-Walrus-Balloon-Guide-Catheter

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière